Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of Spironolactone Use on the Integrity of the XPB-1 Subunit of the TFIIH Complex In Vivo

NCT07415811 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.

NCT NCT07415811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07415811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of Spironolactone Use on the Integrity of the XPB-1 Subunit of the TFIIH Complex In Vivo
Lead sponsor
University of Sao Paulo General Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 24, 2024
Completion date
July 1, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv